Can Tumor Contrast Enhancement Be Used as a Criterion for Differentiating Tumor Grades of Oligodendrogliomas?

References

1. ↵
   Giannini C, Scheithauer BW, Weaver AL, et al. Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 2001;60:248–262

   PubMedWeb of Science
2. ↵
   Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215–225

   PubMedWeb of Science
3. ↵
   Reiche W, Grunwald I, Hermann K, Deinzer M, Reith W. Oligodendrogliomas. Acta Radiol 2002;43:474–482

   CrossRefPubMed
4. ↵
   Margain D, Peretti-Viton P, Perez-Castillo AM, Martini P, Salamon G. Oligodendrogliomas. J Neuroradiol 1991;18:153–160

   PubMedWeb of Science
5. ↵
   Lee YY, Van Tassel P. Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. AJR Am J Roentgenol 1989;152:361–369

   CrossRefPubMedWeb of Science
6. ↵
   Fortin D, Cairncross GJ, Hammond RR. Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 1999;45:1279–1291

   PubMedWeb of Science
7. ↵
   Daumas-Duport C, Tucker ML, Kolles H, et al. Oligodendrogliomas, II: a new grading system based on morphological and imaging criteria. J Neurooncol 1997;34:61–78

   CrossRefPubMed
8. ↵
   Walker DG, Kaye AH. Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review. Australas Radiol 2001;45:472–482

   PubMed
9. ↵
   Leonardi MA, Lumenta CB. Oligodendrogliomas in the CT/MR-era. Acta Neurochir 2001;143:1195–1203
10. ↵
    Cairncross JG, Macdonald DR, Ramsay DA. Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 1992;31:78–82

    PubMedWeb of Science
11. ↵
    Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP. Oligodendrogliomas, I: patterns of growth, histological diagnosis, clinical and imaging correlations—a study of 153 cases. J Neurooncol 1997;34:37–59

    CrossRefPubMed
12. Zagzag D, Goldenberg M, Brem S. Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model. AJR Am J Roentgenol 1989;153:141–146

    PubMed
13. ↵
    Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 1996;27:65–73

    CrossRefPubMed
14. ↵
    Osborn AG. Diagnostic Neuroradiology. St Louis: Mosby-Year Book;1994 :529–578
15. ↵
    Castillo M. Contrast enhancement in primary tumors of the brain and spinal cord. Neuroimaging Clin N Am 1994;4:63–80

    PubMed
16. ↵
    Lee C, Duncan VW, Young AB. Magnetic resonance features of the enigmatic oligodendroglioma. Invest Radiol 1998;33:222–231

    CrossRefPubMed
17. ↵
    Essig M, Hawighorst H, Schoenberg SO, et al. Fast fluid-attenuated inversion-recovery (FLAIR) MRI in the assessment of intraaxial brain tumors. J Magn Reson Imaging 1998;8:789–798

    PubMedWeb of Science
18. ↵
    Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25:214–221

    Abstract/FREE Full Text